In this context, 2 key myeloma markers, MYC and DKK1, as well as many other cancer-associated genes, including ADM, HDGF, IL15, HGF, STMN1, CDKN1B and CD82, were potentially regulated by the predicted ligands (Fig 8C). This evidence concerns the gene CDKN1B and cancer.